Cardiovascular !68% 1 / 16 · unit 3 of 5
What the card badges mean

textbook — checked against your assigned chapter. The standard this exam is measured against.

slides — backed by your instructor's own deck, not (yet) the textbook. A different promise, not a lesser one — she writes the exam from these.

webinar or plain unchecked — nobody has verified this against any source yet. That means unconfirmed, not known wrong.

over any of the above — a caution: only part of the concept is backed, or the wording claims more than its source states.

!conflict — two sources disagree; both versions are on the card.

Pathophysiology of coronary artery disease (CAD)

Topic 24 of 73 textbook

In CAD, the coronary arteries narrow with fatty plaque, so the heart muscle can't get as much oxygen-rich blood as it needs — and that mismatch between oxygen supply and demand is what causes ischemia.

How the plaque builds up (atherosclerosis development):

  1. Endothelial injury — the inner lining of the artery gets damaged, usually from hypertension, smoking, hyperlipidemia, or diabetes.
  2. Lipid accumulation — LDL cholesterol seeps into that damaged lining and gets oxidized, which makes it strongly pro-inflammatory.
  3. Inflammation and immune response — immune cells called macrophages come in to clean up the lipid, gorge on it, and turn into what are called foam cells.
  4. Plaque formation — a fibrous cap forms over the pool of lipid underneath, sealing it into a plaque.

What can go wrong with the plaque:

  • It can rupture — the cap tears, a clot (thrombus) forms on top of it, and that clot can block the artery outright, causing a myocardial infarction.
  • It can just keep growing and cause stenosis — progressive narrowing of the artery.
  • The narrowing causes ischemia — not enough blood getting through — which is felt as angina.

Why the pain shows up with exertion:

At rest, even a narrowed artery can usually deliver enough blood to keep the heart muscle satisfied. But when you exert yourself, the heart muscle's oxygen demand goes up — and the artery is fixed in how narrow it is, so it can't deliver any more blood to meet that demand. The mismatch causes ischemia, which you feel as angina, and it eases again once you rest and demand drops back down.

One-sentence version: atherosclerotic narrowing of the coronary arteries means myocardial oxygen supply cannot meet demand, producing ischemia.

Atherosclerosis development:

  1. ENDOTHELIAL INJURY — from hypertension, smoking, hyperlipidemia, diabetes
  2. LIPID ACCUMULATION — LDL penetrates the endothelium and becomes OXIDIZED, which makes it highly PRO-INFLAMMATORY
  3. INFLAMMATION AND IMMUNE RESPONSE — macrophages engulf lipid and become foam cells
  4. PLAQUE FORMATION — a fibrous cap forms over a lipid core

Plaque complications:

  • RUPTURE → thrombus formation → myocardial infarction
  • STENOSIS → progressive narrowing
  • ISCHEMIA → angina

Why symptoms are exertional: at rest the narrowed artery may supply enough blood. With exertion, myocardial oxygen demand rises but the fixed narrowing cannot deliver more → ischemia → angina, relieved by rest.

Sources for this card

  • Textbook McCance Ch. 32 — atherosclerosis and coronary artery disease

    Confirms that the process begins with injury to the endothelial cells, that oxidised LDL is taken up to form foam cells and a fatty streak, that smooth muscle cells proliferate to form the plaque, and that an unstable plaque has a thin fibrous cap prone to rupture, causing thrombus and infarction.

  • Key Points Unit 3 Key Points — “Coronary Artery Disease”

    Confirms the chain: atherosclerosis narrows the coronary arteries, plaque and macrophage activity drive thrombosis, and the end point is ischemia or infarction via acute coronary syndrome.

Open one and check this card against it. If it disagrees, that is worth reporting.

Modifiable and nonmodifiable risk factors for CAD

Topic 25 of 73 textbook

Some CAD risk factors are things you cannot change; others are things you (or treatment) can act on.

Can't be changed (non-modifiable)Can be changed (modifiable)
Age — risk goes up as you get olderHypertension
Sex — men are at higher risk at a younger age than womenHyperlipidemia (high blood fats)
Genetics and family history of CAD or hyperlipidemiaSmoking
Diabetes mellitus
Obesity
Physical inactivity
Poor diet (high saturated fat)
Other: chronic inflammation, stress
NON-MODIFIABLEMODIFIABLE
Age — risk increases with ageHypertension
Sex — men are at higher risk at a younger age than womenHyperlipidemia
Genetics and family history of CAD or hyperlipidemiaSmoking
Diabetes mellitus
Obesity
Physical inactivity
Poor diet (high saturated fat)
Other: chronic inflammation, stress

Sources for this card

  • Textbook McCance Ch. 32 — risk factors for CAD

    Confirms age, male sex or postmenopausal female, and family history as nonmodifiable, and dyslipidemia, hypertension, smoking, diabetes, obesity, sedentary lifestyle and atherogenic diet as modifiable. Inflammation is discussed separately as a nontraditional risk factor; stress is not named as a CAD risk factor.

  • Key Points Unit 3 Key Points — “Coronary Artery Disease”

    Names hyperlipidemia — raised cholesterol and triglycerides — as a major contributor, and ties it to preload, afterload, contractility and cardiac output. No modifiable/non-modifiable split.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Diagnostic tests for CAD

Background · not on the topic list textbook

The short version: none of these tests on its own says “this is CAD.” Some ask “is the heart short of oxygen right now?”, some ask “does it go short when you make it work?”, and one actually takes a picture of the artery.

What each test is for:

TestWhat it shows
ECG (EKG)A recording of the heart's electrical signals. When heart muscle is short on oxygen the tracing changes shape: the ST segment dips down and the T wave flips upside down. If the ST segment goes up instead, the shortage has gone all the way through the wall of the heart. In your week 2 case the ECG showed the dip — that is what said “this muscle is short on oxygen.”
Exercise stress testThe same ECG, but recorded while you are working — on a treadmill. Here is why it exists: a partly blocked artery can still deliver enough blood while you sit still, so the resting tracing can look completely normal in someone who really does have disease. Making the heart work harder is what exposes it.
Echocardiogram (Echo)An ultrasound picture of the heart — its structure and how well it works. Done during exercise (a stress echo) it is one of the ways to look for narrowed heart arteries without going inside the body. A plain echo is also the test that measures ejection fraction.
Cardiac catheterization / coronary angiogramA thin tube is threaded up into the arteries of the heart and dye is injected so the blockages show up on the screen. Every other test works out that there is a blockage from its effects; this one looks straight at it. There is also a version that uses a CT scanner instead of a tube. That is why it comes last — in your own case the stress test comes first, and this only if the stress test says so.
Lipid profileA blood test for cholesterol and triglycerides. The important bit: this measures the cause, not the damage. It tells you why plaque is building up. It does not tell you whether the heart muscle is short of oxygen today. In your week 2 case: LDL 160, triglycerides 220, HDL 35.
Serum troponinsLEARN THIS ONE TOO — it was not on your list, but the textbook names it right alongside the ECG. Troponin is a protein that leaks out of heart muscle cells when they are actually being damaged. See the box below — this is the one to remember.
Chest x-rayLEARN THIS TOO — not on your list. The textbook includes it in the standard workup for someone with chest pain.
SPECT stress scanLEARN THIS TOO — not on your list. A scan the textbook says is good at spotting oxygen-starved heart muscle and at estimating how much coronary risk someone is carrying.
If you remember one thing from this card: in stable angina the troponin blood test comes back NORMAL. The muscle is starving, but it is not dying yet. The moment troponin starts to rise, the person has moved into something more dangerous — a little bit up in unstable angina, clearly up in a heart attack, where dying muscle cells spill troponin into the blood. Two people can describe exactly the same chest pain; the troponin is what tells them apart.
Two tests on your list are not in any of the material we have: the coronary artery calcium (CAC) scan and the comprehensive metabolic panel (CMP). They are real tests and they are not wrong — but the textbook chapter, all four slide decks, the recordings and the key points mention neither of them for CAD. The only place a CMP turns up in our sources is a chapter about sepsis. So do not count on them being the right answer. If you got these from an eDapt module, tell us and we will add it as a source.

One-sentence version: no single test here diagnoses CAD. The ECG and troponins say whether the muscle is ischemic RIGHT NOW, the stress tests say whether it goes ischemic UNDER DEMAND, and angiography is the one that images the artery itself.

The tests, and what each one is actually for:

TestWhat it shows
Electrocardiogram (ECG/EKG)The heart's electrical activity. In stable angina the characteristic signs are ST-segment DEPRESSION and T-wave INVERSION; ST ELEVATION instead means the ischemia runs through the full thickness of the wall (transmural). Your week 2 case is exactly this — ST depression, read as myocardial ischemia.
Exercise stress testThe same ECG, recorded during exertion. That is the entire point: a fixed narrowing still supplies enough blood at rest, so a resting ECG can be normal in someone who has real disease. Demand is what unmasks it — the same logic as why angina is exertional on the pathophysiology card.
Echocardiogram (Echo)Ultrasound of heart structure and function. Stress echocardiography is one of the noninvasive tests McCance names for evaluating coronary lesions. A plain echo is also what measures ejection fraction.
Cardiac catheterization / coronary angiogramA catheter is threaded to the coronary arteries and contrast dye makes the blockages visible. This is the one that images the artery directly instead of inferring ischemia from its effects. McCance also names coronary CT angiography as a noninvasive way to look at the lesions. Note the sequencing in your own case: a stress test first, angiography only if indicated.
Lipid profileTotal cholesterol, LDL, HDL and triglycerides. This measures the risk factor, not the disease — it says why plaque is forming, not whether the myocardium is ischemic right now. Your week 2 case: LDL 160, triglycerides 220, HDL 35.
Serum troponinsLEARN THIS TOO — it was not on your list, but McCance names it in the same sentence as the ECG for the acute evaluation of chest pain. Released when myocytes are actually injured. See the callout below; this is the highest-yield item on the card.
Chest x-ray (radiography)LEARN THIS TOO — not on your list. McCance lists it with the ECG and troponins in the recommended chest-pain workup.
SPECT stress radionuclide imagingLEARN THIS TOO — not on your list. McCance calls it effective at identifying ischemia and estimating coronary risk.
The highest-yield line on this card: in stable angina, serum troponin stays WITHIN NORMAL LIMITS. The muscle is ischemic but it is not dying. A rising troponin is what moves someone out of stable angina and into an acute coronary syndrome — often slightly raised (hs-troponin I) in unstable angina, and frankly elevated in MI, where dying myocytes release troponins and CPK-MB through damaged membranes into the blood. Two patients can describe the same chest pain; the troponin is what separates them.
Two tests on your list appear in nothing this course gave us: the coronary artery calcium (CAC) scan and the comprehensive metabolic panel (CMP). Both are real tests and neither is wrong — but Ch. 32, all four decks, the recordings and the key points return zero mentions of either for CAD. The only CMP anywhere in our sources is in Ch. 48's sepsis workup. So do not expect them as the keyed answer. If either came from an eDapt module, say so and we will cite it properly.

Sources for this card

  • Textbook McCance Ch. 32 — stable angina pectoris; unstable angina; myocardial infarction

    Confirms the chest-pain workup as ECG, chest radiography and serum troponins; ECG conducted during exercise stress testing; ST depression and T-wave inversion in stable angina, ST elevation as transmural; troponin staying within normal limits in stable angina; and SPECT, stress echo and coronary CT angiography.

  • Slides Week 2 deck, slides 45-46 (objective 7 on slide 6)

    Works the CAD case with a lipid panel, an ECG showing ST-segment depression read as myocardial ischemia, and a referral for a stress test with coronary angiography only if indicated. Objective 7 is to recognise diagnostic approaches for anemia, CAD and heart failure.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Differentiate between HDL and LDL cholesterol

Topic 26 of 73 textbook

Both are ways cholesterol travels through the blood, but they move it in opposite directions.

LDL (low-density lipoprotein) — the "Lousy" one:

LDL carries cholesterol from the liver to the tissues, where it can penetrate the artery wall and deposit there. That's why it's called atherogenic — it's the cholesterol that builds the plaque. Once it gets oxidized inside the artery wall, it becomes strongly pro-inflammatory, which drives the injury-and-plaque process further.

HDL (high-density lipoprotein) — the "Healthy" one:

HDL runs the opposite direction — reverse transport. It picks up excess cholesterol that's sitting in the artery walls and carries it away, back to the liver, where it can be processed and eliminated. That's why HDL is protective.

  • LDL (low-density lipoprotein) — "Lousy." Carries cholesterol FROM the liver TO the tissues, where it penetrates and deposits in artery walls. ATHEROGENIC. Once oxidized it becomes strongly pro-inflammatory.
  • HDL (high-density lipoprotein) — "Healthy." Reverse transport — picks up excess cholesterol from artery walls and carries it AWAY, back to the liver for processing and elimination. PROTECTIVE.

Sources for this card

  • Textbook McCance Ch. 32 — lipoproteins

    Confirms that LDL is responsible for delivering cholesterol to the tissues, that HDL performs reverse cholesterol transport back to the liver, and that high HDL levels are associated with a significant reduction in coronary risk.

Open one and check this card against it. If it disagrees, that is worth reporting.

Total cholesterol ranges (normal vs. high)

Topic 27 of 73 textbook

All the numbers below are in mg/dL.

Optimal / DesirableBorderline highHighVery high
Total cholesterolLess than 200200–239240 or above
LDLLess than 100 optimal / 100–129 near optimal130–159160–189190 or above
HDL60 or above = protective40–60 men / 50–60 womenLow (a risk factor): under 40 men, under 50 women
TriglyceridesLess than 150150–199200–499500 or above
The two numbers most likely to be tested: a total cholesterol of 240 or above is HIGH and carries roughly double the cardiac risk of normal; an HDL of 60 or above is protective, while HDL under 40 in men or under 50 in women is an independent risk factor on its own.

These are verified against NCEP/ATP III — your deck lists the terms but not the numbers, so these are the numbers to actually memorize.

Optimal / DesirableBorderline highHighVery high
TOTAL CHOLESTEROLLess than 200200–239240 or above
LDLLess than 100 optimal / 100–129 near optimal130–159160–189190 or above
HDL60 or above = PROTECTIVE40–60 men / 50–60 womenLOW (a risk factor): under 40 men, under 50 women
TriglyceridesLess than 150150–199200–499500 or above

All values in mg/dL. Two numbers most likely to be tested: total cholesterol of 240 or above is HIGH and carries roughly double the cardiac risk of normal; HDL of 60 or above is PROTECTIVE, while HDL under 40 in men or under 50 in women is an independent risk factor. Verified against NCEP/ATP III — your deck lists the terms but not the numbers.

Sources for this card

  • Textbook McCance Ch. 32, Table 32.4 — lipid reference values

    Matches the card exactly on total cholesterol, LDL and triglyceride bands. For HDL the chapter gives only low below 40 and high at 60 or above, with NO separate male and female thresholds — the card's 50 for women is not in this table.

Careful: this card's wording claims more than its sources give it — including, on some cards, a chapter reference nobody has checked yet. Treat any citation in the text above as unconfirmed unless it appears in this list.

Open one and check this card against it. If it disagrees, that is worth reporting.

Primary and secondary causes of dyslipidemia

Topic 28 of 73 textbook

Dyslipidemia is the umbrella term: any abnormal lipid level, whether it's too high or too low — including a low HDL. Hyperlipidemia is narrower: it specifically means elevated lipids (cholesterol and/or triglycerides).

All hyperlipidemia is dyslipidemia, but not all dyslipidemia is hyperlipidemia — a low HDL, for example, is dyslipidemia without being hyperlipidemia.

Primary causes — genetic:

  • Familial hypercholesterolemia
  • Familial combined hyperlipidemia

Secondary causes (from your deck) — something else is driving the lipid problem:

  • Diabetes mellitus
  • Obesity
  • Hypothyroidism
  • Chronic kidney disease
  • Liver disease
  • Medications (thiazides, beta blockers, corticosteroids, antiretrovirals)
  • Lifestyle factors
  • Other endocrine disorders — polycystic ovary syndrome and Cushing syndrome
  • Dyslipidemia = ANY abnormal lipid level, whether high or low — this includes a low HDL
  • Hyperlipidemia = specifically ELEVATED lipids (cholesterol and/or triglycerides)
  • Takeaway: all hyperlipidemia is dyslipidemia, but not all dyslipidemia is hyperlipidemia
  • PRIMARY causes: genetic — familial hypercholesterolemia, familial combined hyperlipidemia

SECONDARY causes (from your deck):

  • Diabetes mellitus
  • Obesity
  • Hypothyroidism
  • Chronic kidney disease
  • Liver disease
  • Medications (thiazides, beta blockers, corticosteroids, antiretrovirals)
  • Lifestyle factors
  • Other endocrine disorders — POLYCYSTIC OVARY SYNDROME and CUSHING SYNDROME

Sources for this card

  • Textbook McCance Ch. 32 — dyslipidemia

    Defines dyslipidemia and names diabetes, hypothyroidism, pancreatitis and renal nephrosis as secondary causes, with diuretics, glucocorticoids, interferons and antiretrovirals as drug causes. Obesity, PCOS, Cushing syndrome and beta blockers return zero hits, as does any hyperlipidemia contrast.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Pathophysiology of right and left-sided heart failure

Topic 29 of 73 textbook

At its core, heart failure means less blood is being pumped out than the body needs — and the heart's own attempt to compensate ends up making things worse.

The self-reinforcing cycle:

Decreased contractility means the heart squeezes less forcefully, so less blood is pumped out with each beat (decreased stroke volume). Whatever wasn't pumped out is left behind in the ventricle, so more volume builds up there before the next beat — this is an increased left ventricular end-diastolic volume (LVEDV), also called increased preload. That extra volume stretches and enlarges (dilates) the heart, and a dilated heart contracts even less well — feeding right back into decreased contractility. It's a cycle that keeps reinforcing itself.

Left-sided heart failure (the most common kind):

The left ventricle can't pump blood forward efficiently, so blood backs up behind it — into the pulmonary circulation (the lungs). That raises the pressure in the pulmonary vessels, which forces fluid to leak out into the alveoli, causing pulmonary congestion and edema. And because less blood is getting pumped forward in the first place, patients also get fatigue and cool extremities from that reduced output.

Right-sided heart failure:

The right ventricle can't pump blood to the lungs adequately, so blood backs up behind it instead — into the systemic venous circulation (the body). That raises venous pressure, which causes fluid retention, peripheral edema, ascites (fluid in the abdomen), and hepatic congestion (a backed-up liver).

Two ways right-sided failure develops:

  1. Secondary to left-sided failure (most common) — fluid that's backed up from the failing left side works its way back through the lungs and puts strain on the right ventricle.
  2. Without any left-sided failure — from long-standing lung disease, especially COPD, or pulmonary hypertension. This standalone pattern is called cor pulmonale. These patients show jugular venous distention, peripheral edema, and hepatosplenomegaly, but without the lung symptoms you'd see in left-sided failure.

Systolic vs. diastolic dysfunction — two different ways the pump can fail:

Systolic (HFrEF)Diastolic (HFpEF)
The problemPumping — the ventricle can't contractFilling — the ventricle can't relax and stretch
Ejection fraction40% or below (reduced)50% or above (preserved)
VentricleDilated, thin, floppy — chamber enlargedStiff, thickened all around (concentrically hypertrophied) — chamber smaller
Chest X-rayCardiomegalyNormal heart size despite the congestion
Heart soundS3S4

Core pathophysiology: there is less cardiac output to meet the body’s oxygen demands. Decreased contractility → decreased stroke volume → blood is left behind → INCREASED LEFT VENTRICULAR END-DIASTOLIC VOLUME (LVEDV = preload) → dilation of the heart → further decreased contractility. A self-reinforcing cycle.

  • LEFT-SIDED (most common): the left ventricle cannot pump blood forward efficiently → blood backs up into the PULMONARY circulation → increased pulmonary pressures → fluid leaks into the alveoli → pulmonary congestion and edema. Reduced forward output causes fatigue and cool extremities.
  • RIGHT-SIDED: the right ventricle cannot pump blood to the lungs adequately → blood backs up into the SYSTEMIC venous circulation → increased venous pressure → fluid retention, peripheral edema, ascites, hepatic congestion.

Two ways to develop right-sided heart failure:

  1. SECONDARY TO LEFT-SIDED FAILURE (most common) — fluid backs up from the left side through the lungs and strains the right ventricle
  2. WITHOUT left-sided failure — from long-standing pulmonary disease, especially COPD, or pulmonary hypertension. This is COR PULMONALE. These patients show JVD, peripheral edema, and hepatosplenomegaly WITHOUT the pulmonary symptoms of left-sided failure.

Systolic vs. diastolic dysfunction:

SYSTOLIC (HFrEF)DIASTOLIC (HFpEF)
ProblemPUMPING — the ventricle cannot contractFILLING — the ventricle cannot relax and stretch
Ejection fraction40% or below (reduced)50% or above (preserved)
VentricleDilated, thin, floppy — chamber ENLARGEDStiff, concentrically hypertrophied — chamber SMALLER
Chest X-rayCardiomegalyNormal heart size despite congestion
Heart soundS3S4

Sources for this card

  • Textbook McCance Ch. 32, Table 32.7 — heart failure

    Confirms the decreased contractility to decreased stroke volume to raised end-diastolic volume and dilation cycle, and matches the card's systolic-versus-diastolic table on ejection fraction, chamber shape and heart sounds. Cor pulmonale is confirmed as right failure arising from pulmonary disease.

  • Key Points Unit 3 Key Points — “Heart Failure”

    Backs the core split: the left ventricle failing pushes pressure back into the lungs; the right failing pushes it back into the systemic veins, and right-sided failure often follows left.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Risk factors for heart failure

Topic 30 of 73 textbook

The single biggest risk factor is long-standing hypertension.
  • Coronary artery disease and prior myocardial infarction — CAD is a leading cause
  • Diabetes mellitus
  • Valvular heart disease
  • Cardiomyopathy
  • Obesity
  • Chronic lung disease (COPD) and pulmonary hypertension — these drive right-sided failure specifically
  • Anemia — the heart has to work harder to compensate for the blood carrying less oxygen
  • Advancing age
  • Chronic kidney disease
  • Arrhythmias such as atrial fibrillation
  • THE MAJOR RISK FACTOR: LONG-STANDING HYPERTENSION
  • Coronary artery disease and prior myocardial infarction — CAD is a leading cause
  • Diabetes mellitus
  • Valvular heart disease
  • Cardiomyopathy
  • Obesity
  • Chronic lung disease (COPD) and pulmonary hypertension — for right-sided failure
  • Anemia — increases cardiac workload as the heart compensates for reduced oxygen-carrying capacity
  • Advancing age; chronic kidney disease; arrhythmias such as atrial fibrillation

Sources for this card

  • Textbook McCance Ch. 32 — heart failure risk factors

    States that ischemic heart disease and hypertension are the most important predisposing risk factors — JOINTLY. The card calls hypertension THE major one. Diabetes, obesity, valvular disease, cardiomyopathy, age, chronic kidney disease and atrial fibrillation are all confirmed.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Stages of heart failure according to the ACC/AHA

Topic 31 of 73 slidesYour school words it: “Stages of heart failure according to the American College of Cardiology (ACC)/American Heart Association (AHA)”

StageWhat it means
AAt risk — has risk factors (hypertension, CAD, diabetes) but no structural heart damage and no symptoms
BStructural heart damage is present (for example a prior MI, reduced ejection fraction, or left ventricular hypertrophy) — but still no symptoms
CStructural heart disease plus current or previous symptoms — dyspnea, swelling, reduced ability to function day to day. This is the stage where the NYHA classification comes into play.
DEnd-stage / refractory — medications have already been maximized and symptoms are present even at rest. May require transplant, mechanical support, or device therapy.
ACC/AHA stages describe the structure of the heart, and they only move forward — a patient who has reached Stage C never moves back down to Stage B.
StageDefinition
AAT RISK — has risk factors (hypertension, CAD, diabetes) but NO structural heart damage and NO symptoms
BSTRUCTURAL HEART DAMAGE is present (for example a prior MI, reduced EF, or LVH) but STILL NO SYMPTOMS
CStructural heart disease PLUS current or previous SYMPTOMS — dyspnea, swelling, reduced daily function. This is where the NYHA classification comes into play.
DEND-STAGE / refractory — medications have been maximized; symptoms at rest. May require transplant, mechanical support, or device therapy.

ACC/AHA stages are STRUCTURAL and only move FORWARD — a patient never moves back from Stage C to Stage B.

Sources for this card

  • Slides Week 2 deck, slide 64 — Stages of Heart Failure (ACC/AHA)

    Defines Stage A as risk factors without structural damage or symptoms, Stage B as structural damage without symptoms, Stage C as symptomatic with altered daily function, and Stage D as end-stage with maximised medication.

Nobody has checked this card against the assigned textbook yet.

Open one and check this card against it. If it disagrees, that is worth reporting.

Pharmacological management for Stage B and Stage C heart failure

Topic 32 of 73 webinar

StageWhat's given
ATreat the risk factors — control blood pressure, lipids, and diabetes; an ACE inhibitor or ARB where indicated
BAn ACE inhibitor (or ARB) plus a beta blocker, to prevent progression and stop the heart from remodeling further. Consider an ICD if ejection fraction is 30% or below.
CFull guideline-directed medical therapy (GDMT) — all four pillars together: (1) an ARNI, ACE inhibitor, or ARB; (2) a beta blocker; (3) an MRA (aldosterone antagonist); (4) an SGLT2 inhibitor. Plus a diuretic (furosemide) to control symptoms and fluid volume.
DAdvanced therapies — transplant evaluation, mechanical circulatory support, inotropes, palliative care
Critical exam distinction: diuretics only relieve symptoms — they don't extend life. ACE inhibitors/ARNI, beta blockers, MRAs, and SGLT2 inhibitors are the ones that improve survival. So for a patient who is acutely congested and symptomatic right now, the priority is a loop diuretic. Beta blockers, on the other hand, are contraindicated during acute decompensation — they're negative inotropes, meaning they weaken the heart's squeeze, which is the last thing you want mid-crisis. Start them only once the patient is euvolemic (fluid balance has been brought back to normal).
StagePharmacologic management
ATreat the risk factors — control blood pressure, lipids, and diabetes; ACE inhibitor or ARB where indicated
BACE INHIBITOR (or ARB) PLUS BETA BLOCKER — to prevent progression and adverse remodeling. Consider ICD if EF is 30% or below.
CFull GDMT — all four pillars: (1) ARNI, ACE inhibitor, or ARB; (2) BETA BLOCKER; (3) MRA (aldosterone antagonist); (4) SGLT2 INHIBITOR. PLUS DIURETICS (furosemide) for symptom and volume control.
DAdvanced therapies — transplant evaluation, mechanical circulatory support, inotropes, palliative care
CRITICAL EXAM DISTINCTION: diuretics relieve SYMPTOMS. ACE inhibitors/ARNI, beta blockers, MRAs, and SGLT2 inhibitors improve SURVIVAL. For an acutely congested, symptomatic patient the priority is a LOOP DIURETIC. Beta blockers are CONTRAINDICATED during acute decompensation because they are negative inotropes — start them once the patient is euvolemic.

Sources for this card

  • Slides Week 2 deck, slide 46 — pharmacotherapy

    Names a statin for lipids, a beta blocker for blood pressure and further agents, without setting out a stage-by-stage regimen.

  • Webinar Week 2 webinar — heart failure treatment

    Discusses ACE inhibitors, beta blockers, ARNI and diuretics in the context of staged management.

Careful: this card's wording claims more than its sources give it — including, on some cards, a chapter reference nobody has checked yet. Treat any citation in the text above as unconfirmed unless it appears in this list.

Open one and check this card against it. If it disagrees, that is worth reporting.

Purpose of the NYHA Functional Classification of Heart Failure

Topic 33 of 73 !conflict

The NYHA classification answers a different question than the ACC/AHA stages do. The stages describe the structure of the heart and only ever move forward. NYHA instead describes how much the symptoms limit the patient's activity — and unlike the stages, it can move back and forth as treatment helps or the disease worsens. It's used to describe functional capacity in Stage C — your slide 64 brings NYHA in at Stage C specifically, and describes Stage D separately as end-stage. On its own it's an independent predictor of mortality.

ClassHow limited the patient is
IMild — no limitation of physical activity. Ordinary activity doesn't cause symptoms.
IIMild — slight limitation. Comfortable at rest; ordinary physical activity produces fatigue, palpitations, dyspnea, or anginal pain.
IIIModerate — marked limitation. Comfortable at rest; less-than-ordinary activity produces symptoms.
IVSevere — unable to carry out any physical activity without discomfort. Symptoms may be present even at rest and increase with any activity.

Purpose: unlike the ACC/AHA stages, which describe STRUCTURE and move in one direction only, the NYHA classification describes HOW MUCH THE SYMPTOMS LIMIT THE PATIENT’S ACTIVITY — and it CAN MOVE BACK AND FORTH with treatment. Watch the wording: your week 2 slide 65 calls these “Stage I-IV”, but they are normally — and on most exams — called CLASS I-IV. If a question says “Stage III” about symptoms and activity, it means NYHA Class III, not ACC/AHA Stage C. It characterises functional capacity in STAGE C — your slide 64 introduces NYHA at Stage C specifically, and Stage D is described separately as end-stage. NYHA class is an independent predictor of mortality, and unlike the ACC/AHA stage it can improve with treatment.

ClassLimitation
IMILD — no limitation of physical activity. Ordinary activity does not cause symptoms.
IIMILD — slight limitation. Comfortable at rest; ORDINARY physical activity produces fatigue, palpitations, dyspnea, or anginal pain.
IIIMODERATE — marked limitation. Comfortable at rest; LESS THAN ORDINARY activity produces symptoms.
IVSEVERE — unable to carry out any physical activity without discomfort. SYMPTOMS MAY BE PRESENT AT REST and increase with any activity.

Sources for this card

  • Slides Week 2 deck, slide 65 — NYHA Functional Classifications

    Frames the classification as the impact of symptoms on activity, and defines four levels from no limitation of ordinary activity through to symptoms at rest.

Nobody has checked this card against the assigned textbook yet.

Open one and check this card against it. If it disagrees, that is worth reporting.

Signs and symptoms of right and left-sided heart failure, including heart sounds

Topic 34 of 73 textbook

FindingLeft-sidedRight-sided
Blood backs up intoThe lungs (pulmonary circulation)The body (systemic venous circulation)
DyspneaYes — prominentLess prominent
OrthopneaYesNo
Paroxysmal nocturnal dyspneaYesNo
CracklesYes — bilateralNo
CoughYes — pink, frothy sputumNo
Jugular venous distentionNoYes
Peripheral / dependent edemaNoYes
Ascites, hepatomegalyNoYes
Weight gain, bloating, anorexiaLessYes — from hepatic and gut congestion
Cool, pale extremitiesYes — from reduced cardiac output
Heart soundS3 in systolic (HFrEF) · S4 in diastolic (HFpEF)
Memory hooks: LEFT = LUNGS, RIGHT = REST of the body. S3 is heard in systolic failure — think of blood sloshing into a floppy, dilated ventricle. S4 is heard in diastolic failure — think Stiff, the atrium slamming into a ventricle that won't comply.
FindingLEFT-SIDEDRIGHT-SIDED
Blood backs up intoTHE LUNGS (pulmonary circulation)THE BODY (systemic venous circulation)
DyspneaYes — prominentLess prominent
OrthopneaYESNo
Paroxysmal nocturnal dyspneaYESNo
CracklesYes — bilateralNo
CoughYes — PINK, FROTHY SPUTUMNo
Jugular venous distentionNoYES
Peripheral / dependent edemaNoYES
Ascites, hepatomegalyNoYES
Weight gain, bloating, anorexiaLessYES — from hepatic and gut congestion
Cool, pale extremitiesYes — from reduced cardiac output
HEART SOUNDS3 in systolic (HFrEF) · S4 in diastolic (HFpEF)

Memory hooks: LEFT = LUNGS, RIGHT = REST of the body. S3 = Systolic (sloshing into a floppy, dilated ventricle). S4 = Stiff (the atrium slamming into a non-compliant ventricle).

Sources for this card

  • Textbook McCance Ch. 32 — manifestations of heart failure

    Confirms dyspnea, orthopnea, cough of frothy sputum, crackles and S3 on the left, and jugular venous distension, hepatomegaly and peripheral edema on the right. Ascites and cool, pale extremities return zero hits.

  • Key Points Unit 3 Key Points — “Heart Failure”

    Backs the symptom split — breathlessness and pulmonary edema on the left, peripheral edema and hepatomegaly on the right. Says nothing about heart sounds, JVD or orthopnea.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Ejection fraction as a parameter for heart failure

Topic 35 of 73 textbook

Ejection fraction is the percentage of the blood sitting in the ventricle at the end of filling (end-diastolic volume) that actually gets ejected with each beat. Normal is 55–70%. It's measured by echocardiogram, and it's the key number that separates systolic failure from diastolic failure.

CategoryLVEF
HFrEF — reduced ejection fraction40% or below
HFmrEF — mildly reduced ejection fraction41–49%
HFpEF — preserved ejection fraction50% or above
HFimpEF — improved ejection fractionPreviously 40% or below, now above 40%

These four categories come from the 2022 AHA/ACC/HFSA guideline, which is newer than your webinar deck — so if the deck only lists two or three categories, that's why.

  • Ejection fraction is the PERCENTAGE of end-diastolic volume ejected with each beat. Normal is 55–70%.
  • It is measured by echocardiogram and is the key parameter separating systolic from diastolic failure
CategoryLVEF
HFrEF — reduced ejection fraction40% or below
HFmrEF — mildly reduced ejection fraction41–49%
HFpEF — preserved ejection fraction50% or above
HFimpEF — improved ejection fractionPreviously 40% or below, now above 40%

These four categories are from the 2022 AHA/ACC/HFSA guideline, which is newer than your webinar deck.

Sources for this card

  • Textbook McCance Ch. 32 — ejection fraction categories

    Gives HFrEF at 40% or below, HFmrEF 41 to 49%, HFpEF 50% or above, and improved EF as a baseline at or below 40% rising by at least 10 points, with normal stated as 55 to 70%.

Careful: this card's wording claims more than its sources give it — including, on some cards, a chapter reference nobody has checked yet. Treat any citation in the text above as unconfirmed unless it appears in this list.

Open one and check this card against it. If it disagrees, that is worth reporting.

Pathophysiology of the heart valve disorders

Topic 36 of 73 textbookYour school words it: “Pathophysiology of the heart valve disorders: aortic stenosis/regurgitation and mitral stenosis/regurgitation”

The heart has four valves — aortic, mitral, pulmonary, and tricuspid — and each one can fail in one of two directions: it can get too narrow (stenosis), or it can stop closing all the way and let blood leak backward (regurgitation). Left alone, either one can progress all the way to heart failure.

Stenosis:

The valve opening narrows, which restricts how much blood can flow through and forces the heart to work harder to push blood through the smaller opening. The narrowing itself is what produces the murmur you hear, and the extra workload causes the chamber pushing against the narrowed valve to thicken (chamber hypertrophy) — this is called pressure overload. It can also raise the pressure, and potentially cause regurgitation, in the chamber next door.

Regurgitation:

The valve doesn't close all the way, so some blood leaks backward instead of moving forward. Whichever chamber receives that backward flow has to hold extra volume, so it stretches out and enlarges — this is volume overload, and the chamber dilates rather than thickens.

Aortic stenosis — high yield:

The classic triad is angina, syncope, and dyspnea — all brought on by exertion. Of the three, syncope is the most ominous symptom.

Why exercise triggers the fainting (exertional syncope):

  1. The aortic valve is stuck narrow and physically cannot open any wider — it's a fixed obstruction, not one that can flex to let more blood through.
  2. During exercise, your muscles need more blood, so the body relaxes (vasodilates) the blood vessels feeding them — this drops your systemic vascular resistance.
  3. Normally the heart would answer that drop by pumping out more blood to keep blood pressure up. But cardiac output can't increase past the valve's fixed narrow opening — there's simply no more room for blood to get through.
  4. So blood pressure falls anyway, the brain is underfed (cerebral hypoperfusion), and the patient faints.
  5. The medical word for that faint is syncope.

Three causes your course names:

  • Congenital anomalies
  • Age-related degeneration (calcification of the leaflets)
  • Rheumatic heart disease

If it's left untreated, the chronic extra pressure the left ventricle is pushing against (pressure overload) makes it hypertrophy to try to keep output up — but that thickened muscle eventually causes myocardial ischemia, angina, and heart failure of its own.

The only real fix is replacing the valve, and your book is specific about how. The catheter route (TAVI/TAVR) is the one it says is indicated for people who have symptoms and for most people who don't yet, as long as the stenosis is severe. So "just watch and wait" is the wrong answer for severe aortic stenosis, even with no symptoms. Medicines can ease the heart's workload (vasodilators) but they don't fix the valve, and statins specifically have been shown not to slow it down.

Mitral stenosis — high yield:

Worldwide, the most common cause is rheumatic heart disease following a strep throat infection (group A streptococcal pharyngitis) that was never treated. The immune system's antibodies against the strep bacteria cross-react with the valve tissue itself (molecular mimicry) — that cross-reaction thickens the leaflets and fuses them together at their edges (commissural fusion), a process slow enough that it doesn't show up until decades later.

The downstream effects: the left atrium enlarges, which can trigger atrial fibrillation; pressure backs up into the lungs causing pulmonary congestion; engorged pulmonary capillaries can rupture and cause hemoptysis (coughing up blood); and in advanced disease, pulmonary hypertension develops and eventually causes right heart failure with peripheral edema.

Valve disorders involve the aortic, mitral, pulmonary, and tricuspid valves and manifest as narrowing (STENOSIS) or backward leakage (REGURGITATION). Either can progress to heart failure.

  • STENOSIS — the valve opening narrows, limiting blood flow and increasing cardiac workload. This produces murmurs, CHAMBER HYPERTROPHY (pressure overload), and potentially elevated pressure and regurgitation in the adjacent chamber.
  • REGURGITATION — the valve fails to close, allowing backward flow. The chamber receiving the backflow DILATES (volume overload).

Aortic stenosis — high yield:

  • Classic triad: ANGINA, SYNCOPE, DYSPNEA — all EXERTIONAL. Syncope is the most ominous symptom.
  • Why exertional syncope occurs: the stenotic valve is a FIXED obstruction. During exercise the muscles vasodilate and systemic vascular resistance falls, but cardiac output cannot increase past the fixed orifice → blood pressure falls → cerebral hypoperfusion → syncope.
  • Three causes your course names: CONGENITAL ANOMALIES, AGE-RELATED DEGENERATION (leaflet calcification), and RHEUMATIC HEART DISEASE
  • If untreated: chronic pressure overload → the left ventricle hypertrophies to maintain output → myocardial ischemia, angina, and heart failure
  • Treatment: valve REPLACEMENT is the definitive treatment, and the book is specific about which route it means. PERCUTANEOUS (TAVI/TAVR) is what it indicates for SYMPTOMATIC and most ASYMPTOMATIC people with SEVERE stenosis. Surgical replacement it describes more cautiously — may be indicated in selected individuals. Do not answer "watch and wait" for severe asymptomatic disease. Echocardiography assesses severity before symptoms begin. Medical management (vasodilators) reduces resistance to ejection but does not fix the valve; STATINS specifically have NOT been shown to slow progression.

Mitral stenosis — high yield:

  • Most common cause worldwide is RHEUMATIC HEART DISEASE following untreated group A streptococcal pharyngitis. Molecular mimicry causes immune cross-reaction with valve tissue → leaflet thickening and commissural fusion → presenting DECADES later.
  • Consequences: LEFT ATRIAL ENLARGEMENT → ATRIAL FIBRILLATION; pulmonary congestion; hemoptysis from rupture of engorged pulmonary capillaries; in advanced disease, pulmonary hypertension → right heart failure with peripheral edema

Sources for this card

  • Textbook McCance Ch. 32, pp. 1086-1091 — valvular heart disease

    Confirms the stenosis/regurgitation framework across all four valves, aortic stenosis's three common causes, and the rheumatic route to mitral stenosis with atrial enlargement and pulmonary congestion. States valve replacement is indicated for symptomatic and most asymptomatic severe stenosis.

  • Key Points Unit 3 Key Points — “Heart Valve Disorders”

    Names all four valves and the stenosis-versus-regurgitation framework, and gives aortic stenosis three causes: congenital anomaly, age-related degeneration, rheumatic heart disease.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Murmur characteristics of heart valve disorders

Topic 37 of 73 textbook

DisorderTimingQuality and shapeWhere best heard / radiation
Aortic stenosisSystolicHarsh crescendo-decrescendo ("diamond-shaped") ejection murmur2nd right intercostal space, parasternal → radiates to the carotids
Aortic regurgitationDiastolic (early)Soft, high-pitched, blowing, decrescendoBeside the breastbone, in the 2nd, 3rd, or 4th rib space (Erb's point, the 3rd on the left, is inside that range) — and it can carry up to the neck. Best heard sitting up, leaning forward, breathing all the way out.
Mitral stenosisDiastolic (mid)Low-pitched rumble with an opening snap and a loud S1Apex, using the bell of the stethoscope — your textbook says it radiates to the left armpit (axilla). Read the note under the table.
Mitral regurgitationSystolicHolosystolic (pansystolic), "blowing"Apex / 5th left midclavicular line → radiates to the axilla

Simplified — by heart phase · AI GENERATED

Heart phaseAortic valveMitral valveSo a murmur here means
SYSTOLE (squeeze)OPENCLOSEDAortic stenosis or mitral regurgitation
DIASTOLE (fill)CLOSEDOPENAortic regurgitation or mitral stenosis

Simplified — the four, one at a time · AI GENERATED

DisorderWhat is wrong with the valveWhen you hear itSounds like
Aortic stenosis (AS)Too narrow to open properlyWhile the heart squeezesHarsh
Aortic regurgitation (AR)Cannot shut, so blood leaks backWhile the heart fillsBlowing
Mitral stenosis (MS)Too narrow to open properlyWhile the heart fillsRumbling
Mitral regurgitation (MR)Cannot shut, so blood leaks backWhile the heart squeezesBlowing
⚠ AI GENERATED — the two tables above are not from your course materials. We wrote them so the four rows at the top of this card are something you can work out instead of memorise. The facts in it are checked against your textbook: stenosis means the valve is narrowed so it cannot open, regurgitation means it cannot shut so blood leaks backward, and all four timings match the book's own table. It is the way it is laid out that is ours, not the medicine. Nothing here came from your instructor.

Watch the short forms — this one catches people out. MS means mitral stenosis: the rumbling murmur you hear while the heart is FILLING, down at the apex, with a snap as the stiff valve opens. MR means mitral regurgitation: it lasts the whole SQUEEZE and carries out toward the armpit. They are one letter apart and they happen in opposite halves of the heartbeat, yet they sit side by side on nearly every summary chart — **and one of the charts you were sent labels mitral stenosis as (MR), the very same short form as the row below it. Same for the aortic pair: AS happens during the squeeze, AR** during the filling. If a chart's short form and its timing disagree, believe the timing.

Fastest way to sort them on an exam: ask timing first — that is the part that never lets you down. Then radiation. Systolic radiating to the carotids = aortic stenosis. Systolic radiating to the axilla = mitral regurgitation. Diastolic rumble at the apex with an opening snap = mitral stenosis. Diastolic blowing decrescendo at Erb's point = aortic regurgitation.

One more rule of thumb: diastolic murmurs are essentially always pathologic, while some systolic murmurs can be benign.

Where this card comes from, and one thing to watch. Everything in this table now comes from your textbook (chapter 32) — before this, this card had no source behind it at all. But there is one place your book disagrees with almost everyone else. Your book says the mitral stenosis murmur travels out to the left armpit (axilla), and it says so twice. Nearly every other source teaches that this one stays put at the apex and does not travel — and uses "travels to the armpit" as the way to spot mitral regurgitation instead. Your own course notes and slides don't mention murmurs at all, so there's no tiebreaker. What to do with that: don't use "where it travels" to tell the two mitral problems apart. Use the timing. Mitral stenosis is a diastolic murmur (between beats), mitral regurgitation is a systolic one (during the squeeze). That works no matter which version the question is written from.
DisorderTimingQuality and shapeWhere best heard / radiation
AORTIC STENOSISSYSTOLICHarsh CRESCENDO-DECRESCENDO ("diamond-shaped") ejection murmur2nd RIGHT intercostal space, parasternal → RADIATES TO THE CAROTIDS
AORTIC REGURGITATIONDIASTOLIC (early)Soft, high-pitched, BLOWING, DECRESCENDOPARASTERNAL, 2nd-4th intercostal space (Erb's point, the 3rd left, sits inside that range) → MAY RADIATE TO THE NECK. Sit up, lean forward, end-expiration
MITRAL STENOSISDIASTOLIC (mid)Low-pitched RUMBLE with an OPENING SNAP and loud S1APEX, using the BELL → your textbook says it RADIATES TO THE LEFT AXILLA (read the note below — most other sources teach the opposite)
MITRAL REGURGITATIONSYSTOLICHOLOSYSTOLIC (pansystolic), "blowing"APEX / 5th left midclavicular line → RADIATES TO THE AXILLA

Simplified — by heart phase · AI GENERATED

Heart phaseAortic valveMitral valveSo a murmur here means
SYSTOLE (squeeze)OPENCLOSEDAortic stenosis or mitral regurgitation
DIASTOLE (fill)CLOSEDOPENAortic regurgitation or mitral stenosis

Simplified — the four, one at a time · AI GENERATED

DisorderThe valve problemWhen you hear itSounds like
Aortic stenosis (AS)Aortic valve will not OPENSYSTOLE — the squeezeHarsh
Aortic regurgitation (AR)Aortic valve will not SHUTDIASTOLE — the fillBlowing
Mitral stenosis (MS)Mitral valve will not OPENDIASTOLE — the fillRumbling
Mitral regurgitation (MR)Mitral valve will not SHUTSYSTOLE — the squeezeBlowing
⚠ AI GENERATED — the two tables above are not from your course materials. They were written to make the four rows at the top of this card something you can work out rather than memorise. What is IN it is checked: the definitions are the textbook's own — a stenosis is a constricted or narrow valve, so it will not OPEN; a regurgitation is a failure of the valve to shut completely, so it will not CLOSE — and all four timings match Ch. 32's Table 32.6. The medicine is sourced; the arrangement is ours. Nothing here came from your instructor.

Watch the abbreviations — this is a real trap. MS is mitral STENOSIS: the low-pitched DIASTOLIC rumble at the apex, with an opening snap and a loud S1. MR is mitral REGURGITATION: HOLOSYSTOLIC, blowing, radiating to the axilla. One letter apart, opposite halves of the cycle, and they sit next to each other on almost every summary chart — **including one you were sent, which labels mitral stenosis as (MR), the same abbreviation as the row beneath it. Same discipline for the aortic pair: AS is SYSTOLIC, AR** is DIASTOLIC. If a chart's abbreviation and its timing disagree, trust the timing.

Where this card comes from, and one disagreement to know. Everything above is now backed by your textbook (Ch. 32, Table 32.6 and the valve prose) — this card previously had no source at all. One point differs from what you will hear almost everywhere else: your book says the MITRAL STENOSIS murmur radiates to the left axilla, and says it twice. Most teaching holds that the mitral stenosis rumble stays at the apex and does not radiate, using axillary radiation as the tell for mitral REGURGITATION. Your course material takes no position — murmurs appear once in the key points and nowhere in the decks. So do not lean on radiation to separate the two mitral lesions. Lean on timing: stenosis is DIASTOLIC, regurgitation is SYSTOLIC. That works under either version.

Fastest way to sort them: ask TIMING FIRST — it is the only discriminator that never fails. SYSTOLIC radiating to the CAROTIDS = aortic stenosis. SYSTOLIC radiating to the AXILLA = mitral regurgitation. DIASTOLIC rumble at the apex with an opening snap = mitral stenosis. DIASTOLIC blowing decrescendo parasternally = aortic regurgitation. Diastolic murmurs are essentially always pathologic; some systolic murmurs can be benign.

Sources for this card

  • Textbook McCance Ch. 32, pp. 1086-1091 — Table 32.6 and the valve prose

    Gives timing, quality and auscultation site for aortic stenosis, mitral stenosis, aortic and mitral regurgitation. Places both mitral murmurs at the apex with radiation to the left axilla, which differs from the usual teaching that the stenosis rumble does not radiate.

  • Key Points Unit 3 Key Points — “Heart Valve Disorders”

    Barely touches this: stenosis 'leads to murmurs' and nothing further. No timing, quality or radiation for any valve.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.

Risk factors for developing heart valve disorders

Topic 38 of 73 textbook

  • Age — degenerative calcification of the leaflets
  • Untreated streptococcal infection, which can lead to rheumatic fever
  • Congenital abnormality — especially a bicuspid aortic valve, which causes disease to present earlier
  • Infective endocarditis
  • Prior myocardial infarction — can cause the papillary muscle or chordae to rupture, producing acute mitral regurgitation
  • Chest radiation
  • Connective tissue disease such as Marfan syndrome
  • Intravenous drug use

Factors that specifically accelerate aortic stenosis:

  • Hypertension
  • Dyslipidemia
  • Smoking — this is the one that was missing. Your book says aortic stenosis carries many of the same risk factors as coronary artery disease, and gives three examples: high blood pressure, smoking, and abnormal cholesterol. The word it uses is including, so that list isn't the whole set — insulin resistance counts too, because the same chapter lists "diabetes and insulin resistance" among the seven big coronary risk factors. Learn all four.
  • AGE — degenerative calcification of the leaflets
  • UNTREATED STREPTOCOCCAL INFECTION leading to rheumatic fever
  • Congenital abnormality — especially a BICUSPID AORTIC VALVE, which presents earlier
  • Infective endocarditis
  • Prior myocardial infarction — papillary muscle or chordae rupture causes acute mitral regurgitation
  • Chest radiation; connective tissue disease such as Marfan syndrome; intravenous drug use
  • Accelerating factors for aortic stenosis: the book says AS carries many of the CAD risk factors, and names three — HYPERTENSION, SMOKING, DYSLIPIDEMIA. Note the word including: that list is not exhaustive. INSULIN RESISTANCE belongs here too — the same chapter lists "diabetes and insulin resistance" among the seven major CAD risks. So learn all four; SMOKING is the one this card used to be missing.

Sources for this card

  • Textbook McCance Ch. 32, pp. 1086-1091 — valve disorder causes and risk factors

    Names the causes of each lesion and says aortic stenosis carries many of the CAD risk factors, giving hypertension, smoking and dyslipidemia as examples. Its CAD risk list also includes diabetes and insulin resistance.

  • Key Points Unit 3 Key Points — “Heart Valve Disorders”

    Names all four valves and the stenosis-versus-regurgitation framework, and gives aortic stenosis three causes: congenital anomaly, age-related degeneration, rheumatic heart disease.

Only part of this card is covered by the sources listed. The rest is not yet backed by anything we hold.

Open one and check this card against it. If it disagrees, that is worth reporting.